HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >

Sort by: In order: Results/Page Authors/Record:
Export metadata:
Showing results 1 to 20 of 40
 next >
TypeAuthor(s)TitleOther TitlesCitationCitation(alt)Issue Date
articleYue, Junming; Du, Ziyun; Zhou, Fu-Ming; Dong, Peixin; Pfeffer, Lawrence MApplications of CRSIPR/Cas9 in Cancer Research-Cancer Medicine & Anti Cancer Drugs-Mar-2016
articleDong, Peixin; Xiong, Ying; Yue, Junming; Hanley, Sharon J. B.; Watari, HidemichiB7H3 As a Promoter of Metastasis and Promising Therapeutic Target-Frontiers in Oncology-6-Jul-2018
articleAoyama-Kikawa, Satomi; Fujita, Hiromasa; Hanley, Sharon J.B; Kasamo, Mitsunori; Kikuchi, Kokichi; Torigoe, Toshihiko; Matsuno, Yoshihiro; Tamakoshi, Akiko; Sasaki, Takayuki; Matsuura, Motoki; Kato, Yasuhito; Dong, Peixin; Watari, Hidemichi; Saito, Tsuyoshi; Sengoku, Kazuo; Sakuragi, NoriakiComparison of human papillomavirus genotyping and cytology triage, COMPACT Study : Design, methods and baseline results in 14 642 women-Cancer Science-Jun-2018
articleDong, Peixin; Xiong, Ying; Yu, Jiehai; Chen, Lin; Tao, Tang; Yi, Song; Hanley, Sharon J.B.; Yue, Junming; Watari, Hidemichi; Sakuragi, NoriakiControl of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4–miR-18a pathway in cervical cancer-Oncogene-27-Sep-2018
articleDong, Peixin; Xiong, Ying; Konno, Yosuke; Ihira, Kei; Xu, Daozhi; Kobayashi, Noriko; Yue, Junming; Watari, HidemichiCritical Roles of PIWIL1 in Human Tumors : Expression, Functions, Mechanisms, and Potential Clinical Implications-Frontiers in Cell and Developmental Biology-2021
articleDong, Peixin; Gewirtz, David AEditorial : Risks and Benefits of Adjuvants to Cancer Therapies-Frontiers in Oncology-16-May-2022
articleDong, Peixin; Wang, Feng; Chang, Lei; Yue, JunmingEditorial: Non-Coding RNAs in Gastrointestinal and Gynecological Cancers: New Insights Into the Mechanisms of Cancer Therapeutic Resistance-Frontiers in Cell and Developmental Biology-13-May-2022
articleDong, Peixin; Chang, Lei; Yue, JunmingEditorial: Non-coding RNAs in gastrointestinal and gynecological cancers: New insights into the mechanisms of cancer therapeutic resistance, volume II-Frontiers in Cell and Developmental Biology-14-Feb-2023
articleZhao, Guannan; Zhang, Wenjing; Dong, Peixin; Watari, Hidemichi; Guo, Yuqi; Pfeffer, Lawrence M; Tigyi, Gabor; Yue, JunmingEIF5A2 controls ovarian tumor growth and metastasis by promoting epithelial to mesenchymal transition via the TGFβ pathway-Cell & BioscienceCell Biosci7-Apr-2021
articleZhang, Qi; Dong, Peixin; Liu, Xishi; Sakuragi, Noriaki; Guo, Sun-WeiEnhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis-Scientific Reports-28-Jul-2017
articleDong, Peixin; Xiong, Ying; Yue, Junming; Hanley, Sharon J. B.; Kobayashi, Noriko; Todo, Yukiharu; Watari, HidemichiExploring lncRNA-Mediated Regulatory Networks in Endometrial Cancer Cells and the Tumor Microenvironment : Advances and Challenges-Cancers-Feb-2019
articleDong, Peixin; Xu, Daozhi; Xiong, Ying; Yue, Junming; Ihira, Kei; Konno, Yosuke; Watari, HidemichiThe Expression, Functions and Mechanisms of Circular RNAs in Gynecological Cancers-Cancers-Jun-2020
articleIhira, Kei; Dong, Peixin; Xiong, Ying; Watari, Hidemichi; Konno, Yosuke; Hanley, Sharon JB; Noguchi, Masayuki; Hirata, Noriyuki; Suizu, Futoshi; Yamada, Takahiro; Kudo, Masataka; Sakuragi, NoriakiEZH2 inhibition suppresses endometrial cancer progression via miR-361/Twist axis-Oncotarget-21-Feb-2017
articleHuo, Xueyun; Zhang, Wenjing; Zhao, Guannan; Chen, Zhenwen; Dong, Peixin; Watari, Hidemichi; Narayanan, Ramesh; Tillmanns, Todd D; Pfeffer, Lawrence M; Yue, JunmingFAK PROTAC Inhibits Ovarian Tumor Growth and Metastasis by Disrupting Kinase Dependent and Independent Pathways-Frontiers in Oncology-28-Apr-2022
articleLi, Yi; Wu, Anqi; Chen, Lin; Cai, Aiting; Hu, Yuhao; Zhou, Zhou; Qi, Qianyi; Wu, Yixuan; Xia, Donglin; Dong, Peixin; Ju, Shaoqing; Wang, FengHsa_circ_0000098 is a novel therapeutic target that promotes hepatocellular carcinoma development and resistance to doxorubicin-Journal of Experimental & Clinical Cancer Research-7-Sep-2022
articleXiong, Ying; Sun, Fei; Dong, Peixin; Watari, Hidemichi; Yue, Junming; Yu, Min-fei; Lan, Chun-yan; Wang, Yin; Ma, Ze-biaoiASPP induces EMT and cisplatin resistance in human cervical cancer through miR-20a-FBXL5/BTG3 signaling-Journal of Experimental & Clinical Cancer Research-11-Apr-2017
articleMiao, Yu; Konno, Yosuke; Wang, Baojin; Zhu, Lin; Zhai, Tianyue; Ihira, Kei; Kobayashi, Noriko; Watari, Hidemichi; Jin, Xin; Yue, Junming; Dong, Peixin; Fang, MingyanIntegrated multi-omics analyses and functional validation reveal TTK as a novel EMT activator for endometrial cancer-Journal of Translational Medicine-25-Feb-2023
articleJi, Liang; Zhao, Guannan; Zhang, Peng; Huo, Wenying; Dong, Peixin; Watari, Hidemichi; Jia, Limin; Pfeffer, Lawrence M; Yue, Junming; Zheng, JinhuaKnockout of MTF1 Inhibits the Epithelial to Mesenchymal Transition in Ovarian Cancer Cells-Journal of Cancer-2018
articleZhao, Guannan; Wang, Qinghui; Gu, Qingqing; Qiang, Wenan; Wei, Jian-Jun; Dong, Peixin; Watari, Hidemichi; Li, Wei; Yue, JunmingLentiviral CRISPR/Cas9 nickase vector mediated BIRC5 editing inhibits epithelial to mesenchymal transition in ovarian cancer cells-Oncotarget-7-Nov-2017
articleHuo, Wenying; Zhao, Guannan; Yin, Jinggang; Ouyang, Xuan; Wang, Yinan; Yang, Chuanhe; Wang, Baojing; Dong, Peixin; Wang, Zhixiang; Watari, Hidemichi; Chaum, Edward; Pfeffer, Lawrence M.; Yue, JunmingLentiviral CRISPR/Cas9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells-Journal of Cancer-2017
Showing results 1 to 20 of 40
 next >

 

Hokkaido University